MARIANNE: Impact on Current Treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Implications for the Future

J Clin Oncol. 2017 Jan 10;35(2):127-130. doi: 10.1200/JCO.2016.70.2712. Epub 2016 Nov 14.

Author

Komal Jhaveri¹

Affiliation

¹ Komal Jhaveri, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

PMID: 27918726
DOI: 10.1200/JCO.2016.70.2712

No abstract available

Publication types

Editorial
Comment

MeSH terms

Ado-Trastuzumab Emtansine
Antibodies, Monoclonal, Humanized
Breast Neoplasms*
Humans
Maytansine / analogs & derivatives
Receptor, ErbB-2
Taxoids
Trastuzumab*

Substances

Antibodies, Monoclonal, Humanized
Taxoids
Maytansine
ERBB2 protein, human
Receptor, ErbB-2
pertuzumab
Trastuzumab
Ado-Trastuzumab Emtansine